Covid19_manual_annotation  

Documents (39) JSON TSV

source DB source ID text size updated at # proj. # Ann. updated_at
2020PubMed@AikoHIRAKI taxID_32957995 Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated 1.6 KB 2021-06-04 1 24 2021-06-04
2020PubMed@AikoHIRAKI re33213530 Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structure 6.59 KB 2021-06-08 1 332 2021-06-11
2020PubMed@AikoHIRAKI re32970989 SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. We show that SARS-CoV-2 spike pr 1.09 KB 2021-06-10 1 117 2021-06-10
2020PubMed@AikoHIRAKI re32938496 Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized pati 5.84 KB 2021-06-10 1 322 2021-06-11
2020PubMed@AikoHIRAKI re32807241 Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfraction 8.34 KB 2021-06-10 1 471 2021-06-11
2020PubMed@AikoHIRAKI re32798471 Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a 3.78 KB 2021-06-09 1 380 2021-06-10
2020PubMed@AikoHIRAKI re32744052 IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory eff 4.3 KB 2021-06-08 1 404 2021-06-08
2020PubMed@AikoHIRAKI re32610873 Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized p 5.41 KB 2021-06-08 1 444 2021-06-11
2020PubMed@AikoHIRAKI re32442082 Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research. 1. Introductio 7.34 KB 2021-06-09 1 322 2021-06-09
2020PubMed@AikoHIRAKI re32418532 Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SA 5.69 KB 2021-06-07 1 484 2021-06-07